Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mingmu Xunxi Ye is a Traditional Chinese Medicine (TCM) herbal formulation used for the treatment of various ophthalmic conditions, including acute conjunctivitis, dry eye syndrome, and ocular inflammation. The preparation is typically composed of several botanical extracts known for their heat-clearing and detoxifying properties, such as *Chrysanthemum morifolium* (Juhua), *Lonicera japonica* (Honeysuckle), and *Cassia tora* (Juemingzi). It is administered externally through fumigation (exposure of the eyes to the steam of the heated liquid) followed by topical washing of the eyelids and surrounding areas. This dual action helps to improve local blood circulation, reduce inflammation, and alleviate symptoms like redness, itching, and pain. It is commonly produced as a hospital preparation (医院制剂) in various TCM institutions across China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mingmu xunxi ye.